Skip to main content
Home
Articles
Latest Issue
Issue Archive
Online First
Special Issues
Categories
Anemia Resources
HOPA Corner
Web Exclusives
All Web Exclusives
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Case-Based Exchanges
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Biosimilar Resources
Managing Adverse Events in Patients Utilizing Antibody-Drug Conjugate Therapy
Voices From ASCO 2025
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
Quick Quiz
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Online First
Special Issues
Categories
Anemia Resources
HOPA Corner
Web Exclusives
All Web Exclusives
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Case-Based Exchanges
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Biosimilar Resources
Managing Adverse Events in Patients Utilizing Antibody-Drug Conjugate Therapy
Voices From ASCO 2025
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
Quick Quiz
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
Editorial Board
Editorial Process
Advertising Policy
Advertise
Immunotherapy
Evaluation of Serious Immune-Related Adverse Event Incidence in 200-mg Versus 400-mg Pembrolizumab Regimens
Arlet Bacallao Molina, PharmD; Natoya Muirhead, PharmD, BCOP; Erika Rugay, PharmD, BCOP; Karin Thatcher, PharmD, BCPS; Jovino Hernandez, PharmD, BCPS
Read More
Online First
Assessment of Appropriate Anticoagulation in Patients With Multiple Myeloma—A Health-System Specialty Pharmacy Retrospective Evaluation
Addie Planas, PharmD, CSP, CPh; Brittany Alvarez, PharmD, MBA; Beatriz Jimenez Cadilla, PharmD, BCACP; Karina Delgado, PharmD, MBA, BCPS; Jacqualine Igwe, PharmD, BCPS, et al.
Read More
Advancing Merkel-Cell Carcinoma Treatment With Immunotherapy
Read More
Online First
Management of Severe Hypersensitivity Reaction and Serum Sickness in a Case of Aplastic Anemia: Case Report Using Tocilizumab
David C. Sabatino, PharmD, BCOP; Alina Varabyeva, PharmD, BCOP; Joseph Jurcic, MD
Read More
Tisotumab Vedotin With Pembrolizumab in the Treatment of a Patient With Metastatic Vaginal Cancer: A Case Report
Maja Hill, PharmD; Laura Nice, PharmD, BCOP; Casey Moffa, DO; Thomas Krivak, MD
Read More
HARMONI-2 Demonstrating “Significant” Improvement in PFS With Ivonescimab Over Pembrolizumab
Read More
Treatment With Anakinra After Initially Receiving Tocilizumab for Cytokine Release Syndrome
Ailin Kim, PharmD, BCOP; Monank Patel, PharmD, BCOP; Walter Domingo, PharmD, BCOP; Theresa Latchford, RN, MS; Matthew Frank, MD, PhD
Read More
Comparison of Adverse Events Between 2 Pembrolizumab Monotherapy Dosing Regimens
Kateryna Kovalenko, PharmD, BCOP; John Garrett, PharmD, MS, BCPS, BCOP, APh; Kathryn Bollin, MD; Harminder Sikand, PharmD, FCSHP, FASHP, FCCP; Leah Puglisi, MSc
Read More
The Effect of Dosing Schedule on the Incidence of Immune-Related AEs and Infusion Reactions in Patients Receiving Immunotherapy
Solmaz Karimi, PharmD, MS; April K.S. Salama, MD; Brent A. Hanks, MD, PhD; Beiyu Liu, PhD; Alaattin Erkanli, PhD; Theresa Brown, PharmD, BCOP, CPP
Read More
Incidence of Hypothyroidism in Patients with Cancer Receiving Immune Checkpoint Inhibitors
Nada Alsuhebany, BSPharm, PharmD, BCOP; Anastasia Graham, PharmD, MBA, BCOP; Erin Weeda, PharmD, BCPS; Amy Sion, PharmD, BCOP
Read More
1
2
3
4
Page 1 of 4
Results 1 - 10 of 35
